Healthcare & Biotech

How Valeant Pharmaceuticals can unlock 300% gains in VRX stock

By divesting B&L and Salix, Valeant Pharmaceuticals could unlock gains of 300% in VRX stock. Here’s why Valeant stock owners should welcome the deal.

Also posted in HADE Platform, Members | | Tagged , | 2 Comments

3 reasons Celgene Corporation (NASDAQ:CELG) stock owners should not worry about Revlimid

Revlimid sales will remains a catalyst for CELG stock and a big part of Celgene Corporation’s (NASDAQ:CELG) outlook, but there’s more to Celgene stock.

Also posted in HADE Platform, Members | | Tagged , | Leave a comment

3 Simple Reasons I like TG Therapeutics Inc (NASDAQ:TGTX) Stock Long-Term

TG Therapeutics Inc (NASDAQ:TGTX) is an AbbVie (NYSE:ABBV) or Johnson & Johnson (NYSE:JNJ) buyout waiting to happen, good news for TGTX stock owners.

Also posted in Editor's Pick, Members, Mergers & Acquisitions | | Tagged , , , , , | 1 Comment

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Stock: A Biotech Breakout Likely To Continue

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) is a biotechnology company that develops and commercializes new medicines for liver disease.

Also posted in Hot Stocks, Timely Analysis | | Tagged , , | Leave a comment

Is HealthEquity Inc (NASDAQ:HQY) A Trump Stock Worth Owning?

HQY stock is appealing for a couple of reasons. HealthEquity (NASDAQ:HQY) manages Health Care Savings Accounts or HSAs for thousands of employers.

Also posted in Politics | | Tagged , | 11 Comments

Valeant Pharmaceuticals (NYSE:VRX) Stock: Time to Face the Ugly Truth

Valeant Pharmaceuticals (NYSE:VRX) is not Netflix (NASDAQ:NFLX). Bill Ackman’s divestment & VRX stock price suggests an ugly truth for Valeant stock owners.

Also posted in Editor's Pick, Members, Timely Analysis | | Tagged , , , | 3 Comments

Why Celgene Corporation (NASDAQ:CELG) Stock Looks Ready to Breakout

Revlimid, Otezla, and Ozanimod are three Celgene Corporation (NASDAQ:CELG) drugs that will drive CELG stock higher over the next few years.

Also posted in Members | | Tagged , | Leave a comment